ABSTRACT
The development of qualitatively new measurement capabilities is often a prerequisite for critical scientific and technological advances. Here we introduce an unconventional quantum probe, an entangled neutron beam, where individual neutrons can be entangled in spin, trajectory and energy. The spatial separation of trajectories from nanometers to microns and energy differences from peV to neV will enable investigations of microscopic magnetic correlations in systems with strongly entangled phases, such as those believed to emerge in unconventional superconductors. We develop an interferometer to prove entanglement of these distinguishable properties of the neutron beam by observing clear violations of both Clauser-Horne-Shimony-Holt and Mermin contextuality inequalities in the same experimental setup. Our work opens a pathway to a future of entangled neutron scattering in matter.
ABSTRACT
A time-of-flight modulation of intensity by zero effort spectrometer mode has been developed for the Larmor instrument at the ISIS pulsed neutron source. The instrument utilizes resonant spin flippers that employ electromagnets with pole shoes, allowing the flippers to operate at frequencies up to 3 MHz. Tests were conducted at modulation frequencies of 103 kHz, 413 kHz, 826 kHz, and 1.03 MHz, resulting in a Fourier time range of â¼0.1 ns to 30 ns using a wavelength band of 4 Å-11 Å.
ABSTRACT
Structural properties of cohesive powders are dominated by their microstructural composition. Powders with a fractal microstructure show particularly interesting properties during compaction where a microstructural transition and a fractal breakdown happen before compaction and force transport. The study of this phenomenon has been challenging due to its long-range effect and the subsequent necessity to characterize these microstructural changes on a macroscopic scale. For the detailed investigation of the complex nature of powder compaction for various densification states along with the heterogeneous breakdown of the fractal microstructure we applied neutron dark-field imaging in combination with a variety of supporting techniques with various spatial resolutions, field-of-views and information depths. We used scanning electron microscopy to image the surface microstructure in a small field-of-view and X-ray tomography to image density variations in 3D with lower spatial resolution. Non-local spin-echo small-angle neutron scattering results are used to evaluate fitting models later used as input parameters for the neutron dark-field imaging data analysis. Finally, neutron dark-field imaging results in combination with supporting measurements using scanning electron microscopy, X-ray tomography and spin-echo small angle scattering allowed us to comprehensively study the heterogeneous transition from a fractal to a homogeneous microstructure of a cohesive powder in a quantitative manner.
ABSTRACT
Merosin deficient congenital muscular dystrophy 1A (MDC1A) is a very rare autosomal recessive disorder caused by mutations in the LAMA2 gene leading to severe and progressive muscle weakness and atrophy. Although over 350 causative mutations have been identified for MDC1A, no treatment is yet available. There are many therapeutic approaches in development, but the lack of natural history data of the mouse model and standardized outcome measures makes it difficult to transit these pre-clinical findings to clinical trials. Therefore, in the present study, we collected natural history data and assessed pre-clinical outcome measures for the dy2J/dy2J mouse model using standardized operating procedures available from the TREAT-NMD Alliance. Wild type and dy2J/dy2J mice were subjected to five different functional tests from the age of four to 32 weeks. Non-tested control groups were taken along to assess whether the functional test regime interfered with muscle pathology. Respiratory function, body weights and creatine kinase levels were recorded. Lastly, skeletal muscles were collected for further histopathological and gene expression analyses. Muscle function of dy2J/dy2J mice was severely impaired at four weeks of age and all mice lost the ability to use their hind limbs. Moreover, respiratory function was altered in dy2J/dy2J mice. Interestingly, the respiration rate was decreased and declined with age, whereas the respiration amplitude was increased in dy2J/dy2J mice when compared to wild type mice. Creatine kinase levels were comparable to wild type mice. Muscle histopathology and gene expression analysis revealed that there was a specific regional distribution pattern of muscle damage in dy2J/dy2J mice. Gastrocnemius appeared to be the most severely affected muscle with a high proportion of atrophic fibers, increased fibrosis and inflammation. By contrast, triceps was affected moderately and diaphragm only mildly. Our study presents a complete natural history dataset which can be used in setting up standardized studies in dy2J/dy2J mice.
Subject(s)
Laminin/metabolism , Muscle, Skeletal/metabolism , Muscular Dystrophies/metabolism , Muscular Dystrophy, Animal/metabolism , Animals , Creatine Kinase/metabolism , Disease Models, Animal , Female , Laminin/deficiency , Laminin/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Muscle, Skeletal/pathology , Muscular Dystrophies/genetics , Muscular Dystrophy, Animal/geneticsABSTRACT
Limb-girdle muscular dystrophy types 2D and 2F (LGMD 2D and 2F) are autosomal recessive disorders caused by mutations in the alpha- and delta sarcoglycan genes, respectively, leading to severe muscle weakness and degeneration. The cause of the disease has been well characterized and a number of animal models are available for pre-clinical studies to test potential therapeutic interventions. To facilitate transition from drug discovery to clinical trials, standardized procedures and natural disease history data were collected for these mouse models. Implementing the TREAD-NMD standardized operating procedures, we here subjected LGMD2D (SGCA-null), LGMD2F (SGCD-null) and wild type (C57BL/6J) mice to five functional tests from the age of 4 to 32 weeks. To assess whether the functional test regime interfered with disease pathology, sedentary groups were taken along. Muscle physiology testing of tibialis anterior muscle was performed at the age of 34 weeks. Muscle histopathology and gene expression was analysed in skeletal muscles and heart. Muscle histopathology and gene expression was analysed in skeletal muscles and heart. Mice successfully accomplished the functional tests, which did not interfere with disease pathology. Muscle function of SGCA- and SGCD-null mice was impaired and declined over time. Interestingly, female SGCD-null mice outperformed males in the two and four limb hanging tests, which proved the most suitable non-invasive tests to assess muscle function. Muscle physiology testing of tibialis anterior muscle revealed lower specific force and higher susceptibility to eccentric-induced damage in LGMD mice. Analyzing muscle histopathology and gene expression, we identified the diaphragm as the most affected muscle in LGMD strains. Cardiac fibrosis was found in SGCD-null mice, being more severe in males than in females. Our study offers a comprehensive natural history dataset which will be useful to design standardized tests and future pre-clinical studies in LGMD2D and 2F mice.
Subject(s)
Muscular Dystrophies, Limb-Girdle/metabolism , Muscular Dystrophy, Animal/metabolism , Animals , Collagen/metabolism , Female , Lipid Metabolism , Male , Mice, 129 Strain , Mice, Inbred C57BL , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Muscular Dystrophies, Limb-Girdle/pathology , Muscular Dystrophy, Animal/pathology , Myostatin/genetics , Myostatin/metabolism , Signal Transduction , Transcriptome , Transforming Growth Factor beta/metabolismABSTRACT
At least 13 different disease entities affecting the central nervous system, peripheral nervous system and connective tissue of the skin or kidneys are associated with immunoglobulin G4 (IgG4) immune reactivity. IgG4 has always been considered a benign, non-inflammatory subclass of IgG, in contrast to the well-known complement-activating pro-inflammatory IgG1 subclass. A comprehensive review of these IgG4 autoimmune disorders reveals striking similarities in epitope binding and human leukocyte antigen (HLA) associations. Mechanical interference of extracellular ligand-receptor interactions by the associated IgG4 antibodies seems to be the common/converging disease mechanism in these disorders.
Subject(s)
Autoimmune Diseases of the Nervous System/immunology , Immunoglobulin G/immunology , HumansABSTRACT
Autoantibodies against three different postsynaptic antigens and one presynaptic antigen at the neuromuscular junction are known to cause myasthenic syndromes. The mechanisms by which these antibodies cause muscle weakness vary from antigenic modulation and complement-mediated membrane damage to inhibition of endogenous ligand binding and blocking of essential protein-protein interactions. These mechanisms are related to the autoantibody titre, specific epitopes on the target proteins and IgG autoantibody subclass. We here review the role of specific autoantibody-binding epitopes in myasthenia gravis, their possible relevance to the pathophysiology of the disease and potential implications of epitope mapping knowledge for new therapeutic strategies.
Subject(s)
Antigen-Antibody Reactions , Epitope Mapping , Myasthenia Gravis/immunology , Neuromuscular Junction/immunology , Autoantibodies/metabolism , Autoimmunity , Epitope Mapping/methods , Epitope Mapping/trends , Epitopes/metabolism , Humans , Immunoglobulin G/classification , Immunoglobulin G/immunology , Myasthenia Gravis, Autoimmune, Experimental/drug therapy , Receptors, Cholinergic/immunology , Therapies, Investigational/methods , Therapies, Investigational/trendsABSTRACT
Gangliosides are a family of sialylated glycosphingolipids enriched in the outer leaflet of neuronal membranes, in particular at synapses. Therefore, they have been hypothesized to play a functional role in synaptic transmission. We have measured in detail the electrophysiological parameters of synaptic transmission at the neuromuscular junction (NMJ) ex vivo of a GD3-synthase knockout mouse, expressing only the O- and a-series gangliosides, as well as of a GM2/GD2-synthase*GD3-synthase double-knockout (dKO) mouse, lacking all gangliosides except GM3. No major synaptic deficits were found in either null-mutant. However, some extra degree of rundown of acetylcholine release at high intensity use was present at the dKO NMJ and a temperature-specific increase in acetylcholine release at 35 degrees C was observed in GD3-synthase knockout NMJs, compared with wild-type. These results indicate that synaptic transmission at the NMJ is not crucially dependent on the particular presence of most ganglioside family members and remains largely intact in the sole presence of GM3 ganglioside. Rather, presynaptic gangliosides appear to play a modulating role in temperature- and use-dependent fine-tuning of transmitter output.
Subject(s)
Gangliosides/physiology , Neuromuscular Junction/physiology , Synaptic Transmission/genetics , Acetylcholine/metabolism , Analysis of Variance , Animals , Calcium/metabolism , Calcium/pharmacology , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Electric Stimulation/methods , Electrophysiology , Gangliosidoses, GM2/genetics , Mice , Mice, Knockout , Muscle Strength/genetics , N-Acetylgalactosaminyltransferases/deficiency , Neuromuscular Junction/drug effects , Neuromuscular Junction/radiation effects , Respiration/genetics , Sialyltransferases/deficiency , Synaptic Potentials/drug effects , Synaptic Potentials/physiology , Synaptic Potentials/radiation effects , Synaptic Transmission/drug effects , Synaptic Transmission/radiation effects , Temperature , Time FactorsABSTRACT
The severely ataxic and epileptic mouse leaner (Ln) carries a natural splice site mutation in Cacna1a, leading to a C-terminal truncation of the encoded Ca(v)2.1 alpha(1) protein. Ca(v)2.1 is a neuronal Ca(2+) channel, mediating neurotransmitter release at many central synapses and the peripheral neuromuscular junction (NMJ). With electrophysiological analyses we demonstrate severely reduced ( approximately 50%) neurotransmitter release at Ln NMJs. This equals the reduction at NMJs of Cacna1a null-mutant (Ca(v)2.1-KO) mice, which display a neurological phenotype remarkably similar to that of Ln mice. However, using selective Ca(v) channel blocking compounds we revealed a compensatory contribution profile of non-Ca(v)2.1 type channels at Ln NMJs that differs completely from that at Ca(v)2.1-KO NMJs. Our data indicate that the residual function and presence of Ln-mutated Ca(v)2.1 channels precludes presynaptic compensatory recruitment of Ca(v)1 and Ca(v)2.2 channels, and hampers that of Ca(v)2.3 channels. This is the first report directly showing at single synapses the deficits and plasticity in transmitter release resulting from the Ln mutation of Cacna1a.
Subject(s)
Acetylcholine/metabolism , Calcium Channels, N-Type/genetics , Calcium Channels/genetics , Neuromuscular Junction/genetics , Neuromuscular Junction/metabolism , Synaptic Transmission/genetics , Adaptation, Physiological/genetics , Animals , Calcium Channels, R-Type/genetics , Cation Transport Proteins/genetics , Mice , Mice, Knockout , Mice, Neurologic Mutants , Muscle Fibers, Skeletal/metabolism , Muscle, Skeletal/innervation , Muscle, Skeletal/metabolism , Muscle, Skeletal/physiopathology , Muscular Atrophy/genetics , Muscular Atrophy/metabolism , Muscular Atrophy/physiopathology , Mutation/genetics , Neuromuscular Junction/physiopathology , Protein Subunits/geneticsABSTRACT
Neurotransmission at chemical synapses of the brain involves alpha-neurexins, neuron-specific cell-surface molecules that are encoded by three genes in mammals. Deletion of alpha-neurexins in mice previously demonstrated an essential function, leading to early postnatal death of many double-knockout mice and all triple mutants. Neurotransmitter release at central synapses of newborn knockouts was severely reduced, a function of alpha-neurexins that requires their extracellular sequences. Here, we investigated the role of alpha-neurexins at neuromuscular junctions, presynaptic terminals that lack a neuronal postsynaptic partner, addressing an important question because the function of neurexins was hypothesized to involve cell-adhesion complexes between neurons. Using systems physiology, morphological analyses and electrophysiological recordings, we show that quantal content, i.e. the number of acetylcholine quanta released per nerve impulse from motor nerve terminals, and frequency of spontaneous miniature endplate potentials at the slow-twitch soleus muscle are reduced in adult alpha-neurexin double-knockouts, consistent with earlier data on central synapses. However, the same parameters at diaphragm muscle neuromuscular junctions showed no difference in basal neurotransmission. To reconcile these observations, we tested the capability of control and alpha-neurexin-deficient diaphragm neuromuscular junctions to compensate for an experimental reduction of postsynaptic acetylcholine receptors by a compensatory increase of presynaptic release: Knockout neuromuscular junctions produced significantly less upregulation of quantal content than synapses from control mice. Our data suggest that alpha-neurexins are required for efficient neurotransmitter release at neuromuscular junctions, and that they may perform a role in the molecular mechanism of synaptic homeostasis at these peripheral synapses.
Subject(s)
Nerve Tissue Proteins/physiology , Neuromuscular Junction/physiology , Synapses/physiology , Animals , Diaphragm/innervation , Disease Models, Animal , Electrophysiology/methods , Homeostasis , Mice , Mice, Knockout , Myasthenia Gravis/physiopathology , Nerve Tissue Proteins/deficiency , Nerve Tissue Proteins/genetics , Peripheral Nervous System/physiology , Peripheral Nervous System/physiopathology , Synaptic Transmission/physiologyABSTRACT
Ca(v)2.1 channels mediate neurotransmitter release at the neuromuscular junction (NMJ) and at many central synapses. Mutations in the encoding gene, CACNA1A, are thus likely to affect neurotransmitter release. Previously, we generated mice carrying the R192Q mutation, associated with human familial hemiplegic migraine type-1, and showed first evidence of enhanced presynaptic Ca(2+) influx [Neuron 41 (2004) 701]. Here, we characterize transmitter release in detail at mouse R192Q NMJs, including possible gene-dosage dependency, progression of changes with age, and associated morphological damage and muscle weakness. We found, at low Ca(2+), decreased paired-pulse facilitation of evoked acetylcholine release, elevated release probability, and increased size of the readily releasable transmitter vesicle pool. Spontaneous release was increased over a broad range of Ca(2+) concentrations (0.2-5mM). Upon high-rate nerve stimulation we observed some extra rundown of transmitter release. However, no clinical evidence of transmission block or muscle weakness was found, assessed with electromyography, grip-strength testing and muscle contraction experiments. We studied both adult ( approximately 3-6 months-old) and aged ( approximately 21-26 months-old) R192Q knockin mice to assess effects of chronic elevation of presynaptic Ca(2+) influx, but found no additional or progressive alterations. No changes in NMJ size or relevant ultrastructural parameters were found, at either age. Our characterizations strengthen the hypothesis of increased Ca(2+) flux through R192Q-mutated presynaptic Ca(v)2.1 channels and show that the resulting altered neurotransmitter release is not associated with morphological changes at the NMJ or muscle weakness, not even in the longer term.
Subject(s)
Calcium Channels, P-Type/genetics , Calcium Channels, Q-Type/genetics , Gene Dosage , Muscle Weakness/genetics , Neuromuscular Junction/metabolism , Neurotransmitter Agents/metabolism , Synapses/metabolism , Synapses/ultrastructure , Acetylcholine/metabolism , Aging/physiology , Animals , Apoptosis/physiology , Bungarotoxins , Calcium Channels, N-Type , Coloring Agents , Electric Stimulation , Electromyography , Electrophysiology , Hand Strength/physiology , Humans , Image Processing, Computer-Assisted , Mice , Mice, Transgenic , Microscopy, Electron , Muscle Contraction/physiology , Muscle Weakness/physiopathology , Synaptic Transmission/physiologySubject(s)
Calcium Channels, N-Type/genetics , Mutation , Neuromuscular Junction/metabolism , Neurotransmitter Agents/metabolism , Acetylcholine/analysis , Animals , Calcium Channel Blockers/pharmacology , Calcium Channels, N-Type/metabolism , Diaphragm/drug effects , Diaphragm/metabolism , Diaphragm/physiopathology , Electric Stimulation , Electrophysiology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , In Vitro Techniques , Mice , Mice, Neurologic Mutants , Neuromuscular Junction/drug effects , Neurotransmitter Agents/deficiency , Neurotransmitter Agents/genetics , Species Specificity , omega-Agatoxin IVA/pharmacologySubject(s)
Gangliosides/physiology , N-Acetylgalactosaminyltransferases/genetics , Neuromuscular Junction/physiology , Animals , Antibodies/pharmacology , Autoantibodies/pharmacology , Botulinum Toxins, Type A/pharmacology , Electric Stimulation , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Gangliosides/immunology , Humans , Mice , Mice, Knockout , Miller Fisher Syndrome/blood , Miller Fisher Syndrome/immunology , Neuromuscular Agents/pharmacology , Neuromuscular Junction/drug effects , Neuromuscular Junction/genetics , Phrenic Nerve/physiologySubject(s)
Myasthenia Gravis/physiopathology , Nerve Tissue Proteins , Neuromuscular Junction/physiopathology , Neuronal Plasticity/physiology , Proteins/physiology , Vesicular Transport Proteins , Animals , Bungarotoxins/pharmacology , Disease Models, Animal , Dose-Response Relationship, Radiation , Electric Stimulation , Electrophysiology , Evoked Potentials , Heterozygote , Mice , Mice, Knockout , Munc18 Proteins , Phrenic Nerve/physiopathology , Proteins/genetics , Proteins/metabolism , Receptors, Cholinergic/drug effects , Receptors, Cholinergic/physiologyABSTRACT
To investigate the role of neurotransmitter secretion in the development and stabilization of synapses, the innervation of the diaphragm and intercostal muscles was studied in munc18-1 null mutant mice, which lack regulated secretion. We found that this mutant is completely devoid of both spontaneous and evoked neuromuscular transmission throughout embryonic development. At embryonic day (E) 14, axonal targeting and main branching of the phrenic nerve were normal in this mutant, but tertiary branches were elongated and no terminal branches were observed at this stage, in contrast to control littermates. Acetylcholinesterase staining was observed in the endplate region of mutant muscle from E14 onwards, but not as dense and confined to spots as in controls. Acetylcholine receptor staining was also present in the endplate region of the mutant muscle. In this case, the staining density and the concentration in spots (clusters) were similar to controls, but the distribution of these clusters was less organized. Starting at E15, some receptor clusters co-localized with nerve terminal staining, suggesting synapses, but most clusters remained a-neural. Electron microscopical analysis confirmed the presence of synaptic structures in the mutant. Between E14 and birth, the characteristic staining pattern of nerve branches gradually disappeared in the mutant until, at E18, an elaborate meshwork of nerve fibers with no apparent organization remained. In the same period, most of the motor neuronal cell bodies in the spinal cord degenerated. In contrast, sensory ganglia in the dorsal root showed no obvious degeneration. These data suggest that regulated secretion is not essential for initial axon path finding, clustering of acetylcholine receptors, acetylcholinesterase or the formation of synapses. However, in the absence of regulated secretion, the maintenance of the motor neuronal system, organization of nerve terminal branches and stabilization of synapses is impaired and a-neural postsynaptic elements persist.
Subject(s)
Diaphragm/innervation , Intercostal Muscles/innervation , Nerve Tissue Proteins , Neuromuscular Junction/growth & development , Peripheral Nervous System/growth & development , Proteins , Synapses , Vesicular Transport Proteins , Acetylcholinesterase/analysis , Acetylcholinesterase/metabolism , Animals , Electrophysiology , GAP-43 Protein/analysis , GAP-43 Protein/metabolism , Mice , Mice, Mutant Strains , Microscopy, Electron , Munc18 Proteins , Neuromuscular Junction/embryology , Neuromuscular Junction/metabolism , Peripheral Nervous System/embryology , Peripheral Nervous System/metabolism , Proteins/genetics , Receptors, Nicotinic/analysis , Receptors, Nicotinic/metabolism , Synapses/metabolism , Synapses/pathology , Synapsins/analysis , Synapsins/metabolism , Synaptic TransmissionSubject(s)
Acetazolamide/administration & dosage , Migraine Disorders/drug therapy , Migraine Disorders/physiopathology , Neuromuscular Junction/drug effects , Neuromuscular Junction/physiopathology , Synapses/drug effects , Adult , Calcium Channels, N-Type , Electromyography/methods , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neuromuscular Junction Diseases/complications , Neuromuscular Junction Diseases/drug therapy , Neuromuscular Junction Diseases/physiopathology , Treatment OutcomeABSTRACT
The pathophysiological mechanisms of migraine are not yet very well understood. The gene CACNA1A, coding for the alpha 1A subunit of neuronal P/Q-type Ca2+ channels is mutated in the rare Mendelian inherited variant, familial hemiplegic migraine. This finding suggests a role for disturbed neuronal Ca2+ influx and/or homeostasis in the pathophysiology of migraine. It has stimulated in vitro electrophysiological investigations into the function of mutant human and mouse P/Q-type channels at cell bodies and synapses. A complex picture has emerged from this work, showing that different CACNA1A mutations lead to different effects on Ca2+ channel behavior and that synaptic transmission may become affected. We will review these studies and discuss the possible implications for the understanding of migraine pathophysiology.
Subject(s)
Calcium Channels, P-Type/genetics , Calcium Channels, P-Type/physiology , Calcium Channels, Q-Type/genetics , Calcium Channels, Q-Type/physiology , Migraine Disorders/genetics , Migraine Disorders/physiopathology , Animals , Electrophysiology , Hemiplegia/etiology , Hemiplegia/physiopathology , Humans , Mice , Mutation/genetics , Synapses/physiologyABSTRACT
Miller-Fisher syndrome is an autoimmune neuropathy characterized by ataxia, areflexia and ophthalmoplegia, and in the majority of cases the presence of high titres of anti-GQ1b ganglioside antibodies. In an ex vivo model, human and mouse anti-GQ1b antibodies have been shown previously to induce a complement-dependent alpha-latrotoxin-like effect on the murine motor endplate, i.e. they bring about massive quantal release of acetylcholine and eventually block neuromuscular transmission. Using immunofluorescence microscopy with image analysis, we show here that the late stages of this electrophysiological effect temporally coincide with the loss of heavy neurofilament (200 kDa) and type III beta-tubulin immunostaining and structural breakdown of the nerve terminal, as demonstrated by electron microscopy. Ultrastructurally, axon terminals were disorganized, depleted of vesicles, and subdivided by the infiltrating processes of capping Schwann cells. These findings provide clear pathological evidence to support a role for anti-ganglioside antibodies in mediating nerve terminal injury and further advance the view that this site may be of importance as a target in some human neuropathies.
Subject(s)
Autoantibodies/adverse effects , Complement Activation/immunology , Gangliosides/immunology , Miller Fisher Syndrome/immunology , Neuromuscular Junction/immunology , Alkaline Phosphatase/pharmacology , Animals , Disease Models, Animal , Gangliosides/antagonists & inhibitors , Image Processing, Computer-Assisted , In Vitro Techniques , Male , Mice , Microscopy, Electron , Microscopy, Fluorescence , Miller Fisher Syndrome/pathology , Miller Fisher Syndrome/physiopathology , Motor Neurons/immunology , Motor Neurons/metabolism , Motor Neurons/pathology , Neurofilament Proteins/metabolism , Neuromuscular Junction/metabolism , Neuromuscular Junction/pathology , Neuromuscular Junction/physiopathology , Phosphorylation/drug effects , Schwann Cells/pathology , Schwann Cells/ultrastructure , Synaptic Transmission/drug effects , Synaptic Transmission/immunology , Tubulin/metabolismABSTRACT
Miller Fisher syndrome (MFS) is clinically characterized by ataxia, areflexia, and ophthalmoplegia, and is associated with serum anti-GQ1b-ganglioside antibodies. We have previously shown that anti-GQ1b antibodies induce complement-dependent, alpha-latrotoxin-like effects at mouse neuromuscular junctions (NMJs) in vitro. This effect comprises a massive increase in spontaneous quantal acetylcholine (ACh) release, accompanied by block of evoked release and muscle paralysis. This mechanism may contribute to the motor features of MFS. Whether the block of evoked ACh release is a primary effect of anti-GQ1b antibodies or occurs secondary to massive complement-dependent spontaneous release is unknown. Using conventional micro-electrode methods, we measured in detail ACh release evoked with low- and high-rate nerve stimulation, and studied the effect on it of a purified MFS IgG and a mouse monoclonal anti-GQ1b IgM (without added complement). We found that evoked transmitter release was unaffected. Control experiments proved binding of anti-GQ1b antibody at the NMJ. We conclude that the block of nerve-evoked ACh release at the NMJ is not a primary effect of anti-GQ1b antibodies, but is dependent on antibody-mediated complement activation. It remains to be determined whether the block of nerve-evoked ACh release is the consequence of massive spontaneous ACh release or occurs as a concomitant event.
Subject(s)
Acetylcholine/metabolism , Antibodies, Monoclonal/pharmacology , Gangliosides/immunology , Motor Endplate/metabolism , Nerve Growth Factors/immunology , Action Potentials/drug effects , Action Potentials/physiology , Animals , Complement System Proteins/pharmacology , Electrophysiology , Fluorescent Antibody Technique, Direct , Humans , Immunoglobulin G/immunology , Immunohistochemistry , Male , Mice , Microelectrodes , Motor Endplate/drug effectsABSTRACT
Neurotransmitter release at many synapses is regulated by P/Q-type Ca(2+) channels containing the alpha(1A) pore-forming subunit. Mutations in alpha(1A) cause cerebral disorders including familial hemiplegic migraine (FHM) and ataxia in humans. Tottering (tg) alpha(1A) mutant mice display ataxia and epilepsy. It is not known whether alpha(1A) mutations induce impairment of synaptic function, which could underlie the symptoms of these cerebral disorders. To assess whether alpha(1A) mutations influence neurotransmitter release, we studied P-type Ca(2+) channel-mediated acetylcholine (ACh) release at tg neuromuscular junctions (NMJs) with micro-electrode measurements of synaptic potentials. We found a Ca(2+)-, Mg(2+)- and K(+)-dependent increase of spontaneous ACh release at both homo- and heterozygote tg NMJs. Furthermore, there was increased run-down of high-rate evoked release at homozygous tg NMJs. In isotonic contraction experiments this led to block of synaptic transmission at lower concentrations of the ACh antagonist tubocurarine than were needed in wild-type muscles. Our results suggest that in tg motor nerve terminals there is increased influx of Ca(2+) under resting conditions. This study shows that functional consequences of alpha(1A) mutations causing cerebral disorders can be characterized at the NMJ.